Biotechnology. Venture funds
|
№
|
Name
|
Fund
|
|
1
|
Novartis Venture Fund
|
$1 billion
|
|
2
|
Roche Venture Fund
|
$552.5 million
|
|
3
|
Lilly Asia Ventures
|
$430 million
|
|
4
|
MedImmune Ventures (AstraZeneca)
|
$400 million
|
|
5
|
Merck Research Laboratories Ventures (Merck & Co.)
|
$250 million
|
|
6
|
Astellas Venture Management (AVM)
|
$200 million
|
|
7
|
(tie) Novartis Option Fund
|
$200 million
|
|
8
|
(tie) Lilly Ventures
|
$200 million
|
|
9
|
(tie) Amgen Ventures
|
$200 million
|
|
10
|
MS Ventures (Merck KGaA)
|
$155 million
|
|
11
|
Boehringer Ingelheim Venture Fund (BIVF)
|
$110.5 million
|
|
12
|
MP Healthcare Venture Management (MPH; Mitsubishi Tanabe Pharma Group)
|
$100 million
|
|
13
|
Merck Serono Entrepreneur Partnership Program (EPP; Merck KGaA)
|
$33 million
|
|
14
|
Novartis Korea Venture Fund
|
$20 million
|
|
15
|
MS Ventures Israel Bioincubator Fund (Merck KGaA)
|
$11 million
|
Source: genengnews.com